Communications Biology (May 2024)

The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells

  • Pauline de Zeeuw,
  • Lucas Treps,
  • Melissa García-Caballero,
  • Ulrike Harjes,
  • Joanna Kalucka,
  • Carla De Legher,
  • Katleen Brepoels,
  • Kristel Peeters,
  • Stefan Vinckier,
  • Joris Souffreau,
  • Ann Bouché,
  • Federico Taverna,
  • Jonas Dehairs,
  • Ali Talebi,
  • Bart Ghesquière,
  • Johan Swinnen,
  • Luc Schoonjans,
  • Guy Eelen,
  • Mieke Dewerchin,
  • Peter Carmeliet

DOI
https://doi.org/10.1038/s42003-024-06186-6
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Endothelial cells (ECs) are highly glycolytic, but whether they generate glycolytic intermediates via gluconeogenesis (GNG) in glucose-deprived conditions remains unknown. Here, we report that glucose-deprived ECs upregulate the GNG enzyme PCK2 and rely on a PCK2-dependent truncated GNG, whereby lactate and glutamine are used for the synthesis of lower glycolytic intermediates that enter the serine and glycerophospholipid biosynthesis pathways, which can play key roles in redox homeostasis and phospholipid synthesis, respectively. Unexpectedly, however, even in normal glucose conditions, and independent of its enzymatic activity, PCK2 silencing perturbs proteostasis, beyond its traditional GNG role. Indeed, PCK2-silenced ECs have an impaired unfolded protein response, leading to accumulation of misfolded proteins, which due to defective proteasomes and impaired autophagy, results in the accumulation of protein aggregates in lysosomes and EC demise. Ultimately, loss of PCK2 in ECs impaired vessel sprouting. This study identifies a role for PCK2 in proteostasis beyond GNG.